Abbott Laboratories Allows Further Investigation On Meridia
October 10th, 2010 - 7:23 pm ICT by GDBy Meena Kar
Authorities have confirmed that the investigations on the side-effects of Meridia, a prescription weight loss drug, will continue. Meridia has come under investigation for one of its constituents, sibutramine, which is an appetite suppressant. Meridia is manufactured by Abbott Laboratories which agreed for the investigation after being requested by the FDA. The FDA made the request after the Sibutramine Cardiovascular Outcomes Trial (SCOUT) provided the report.
In a recent study, it was revealed that Meridia caused the risk of heart problems to increase for those who already have a history of heart related diseases. Earlier there were concerns about the effect of Meridia with heart problems. On Friday, the federal health officials have confirmed that the drug has been withdrawn from the United States markets. In Taiwan, Meridia has been recalled by the health authorities for cardiovascular health concerns and on Saturday, the drug was withdrawn from the market for the same reasons.
The DOH (Department of Health) said that it was advised by the European Union that the country put a restriction on all the weight loss drugs containing sibutramine. Meridia, being the best known among the weight loss drug has been the most highlighted by the media. More than 300 people complained of uneasiness after using the drug and more than hundred of them were related to cardiovascular problems. Abbott Laboratories have also agreed to withdraw the drug from the market after the studies proved that there was a 16% increase in the risk of heart attack and stroke due to the consumption of the appetite suppressant which impacts the part of the brain that controls appetite.
- Keller Rohrback investigates Abbot Laboratories regarding weight loss drug - Oct 10, 2010
- Keller Rohrback to continue investigation of Abbot Laboratories' weight loss drug Merida - Oct 10, 2010
- China bans 15 products over heart disease concern - Nov 01, 2010
- FDA Issues Warning About Diet Pill, Stating Risk Of Heart Ailment - Jan 23, 2010
- FDA issues warning about the diet pill Meridia - Jan 24, 2010
- Weight loss pill linked to heart attacks, stroke risk - Jan 04, 2010
- Bristol Myers Get Approval For Their Diabetes Drug - Nov 07, 2010
- Europe bans anti-obesity drug Reductil - Jan 26, 2010
- Weight loss pill 'could be deadly' - Jan 17, 2010
- 'Miracle' diet drug 'linked to deaths of thousands' in France - Dec 28, 2010
- Weight loss supplements are no good - Mar 07, 2012
- FDA Advisory Committee Rejects Vivus Inc. Weight Loss Pill - Jul 19, 2010
- Why drugs increase risk of heart attacks, strokes - Feb 24, 2011
- FDA Advisory Panel Recommends Contrave's Approval - Dec 09, 2010
- Heart drug cuts prostate cancer risk - Apr 03, 2011
Tags: abbott laboratories, appetite suppressant, cardiovascular health, cardiovascular outcomes, cardiovascular problems, constituents, department of health, european union, federal health officials, health authorities, health concerns, heart attack, heart problems, meridia, prescription weight loss, restriction, risk of heart attack, scout, sibutramine, weight loss drugs
